Skip to content
Whitehawk Therapeutics
  • About Us
    • Who We Are
    • Leadership
    • Board of Directors
  • Technology
  • Pipeline
    • Pipeline
    • HWK-007
    • HWK-016
    • HWK-206
  • Investors & News
  • Contact Us
LinkedIn icon
Whitehawk Therapeutics
  • About Us
    • Who We Are
    • Leadership
    • Board of Directors
  • Technology
  • Pipeline
    • Pipeline
    • HWK-007
    • HWK-016
    • HWK-206
  • Investors & News
  • Contact Us
LinkedIn icon

Contact Us

info@whitehawktx.com

IR@whitehawktx.com

(551) 321-2234

map marker icon

2 Headquarters Plaza, East Building, 11th Floor, Morristown, NJ, 07960

Careers

View All Open Positions

Contact Header

Recent News

April 10, 2026

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026

Read article

March 17, 2026

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Read article

March 12, 2026

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Read article

VIEW ALL PRESS RELEASES

© Whitehawk Therapeutics, Inc. All rights reserved

  • Privacy Policy
  • Terms & Conditions
LinkedIn icon